Monday, April 15, 2024
Outlook.com
Outlook India
Outlook Business

Wipro Consumer Care - Ventures Invests in Gynoveda, A Women’s Healthcare Focused Company

Gynoveda is focused on addressing women’s healthcare issues including gynecological and lifestyle-related disorders faced by them from puberty to menopause

Wipro Consumer Care - Ventures Invests in Gynoveda, A Women’s Healthcare Focused Company

Outlook Start-Up Desk

POSTED ON March 27, 2023 1:33 PM

Wipro Consumer Care - Ventures, the venture capital arm of Wipro Consumer Care and Lighting, has invested in Gynoveda which is focused on addressing women’s healthcare issues including gynecological and lifestyle-related disorders faced by them from puberty to menopause.

Gynoveda was founded in 2019 by the husband-wife duo Rachana Gupta and Vishal Gupta along with gynecologist Dr Aarati Patil in an attempt to help women aged between 14 and 45 years to cure disorders such as infertility, poly cystic ovarian syndrome (PCOS), irregular menstrual cycles, etc.

"We believe that there are large unaddressed needs of women who suffer and live with these problems where Gynoveda is already making a visible impact with their offerings as well as educational initiatives. The strong team of Vishal, Rachna and Aarti has all the elements to make Gynoveda formidable with the aim of reaching a larger population.” said Sumit Keshan, managing partner, Wipro Consumer Care - Ventures. 

“This is aligned with our interests in the health and wellness space, in addition to our existing focus on personal care, fragrances, food, nutrition, etc. This is the 10th investment from our fund” he added.

“Our philosophy is that we can solve gynecological disorders for women, without putting them on life-long medications. We can help them get rid of gynecological problems in a time period of 6-8 months or one year, based on their chronicity,” co-founder and CEO Vishal Gupta said. “Gynoveda has so far improved the health of 3 lakh women residing in 20,000 pin codes of India” he added.

With an aim to revolutionise the $9.6 billion global women’s healthcare industry, Gynoveda sells proprietary formulations certified by the United States Food and Drug Administration (FDA) and India’s National Accreditation Board for Testing and Calibration Laboratories. It sells these products via its website as well as e-commerce marketplaces such as Amazon, Flipkart and Nykaa. They have strong initiatives on providing expert consultations thru tele-consultation mode, educational materials thru blogs and videos, webinars etc.

  • Related Articles

    Honasa Consumer Ltd, the parent company of Mamaearth, filed its draft red herring prospectus with the Securities and Exchange Board of India (SEBI) for an initial public offering (IPO) in December...

    Honasa Consumer Ltd, Parent Company of Mamaearth, Puts IPO On Hold: Report

    The platform employs sophisticated intent detection technology to provide personalised product and service recommendations, facilitating swift transactions for brands and business partners

    Bobble AI Launches Conversational Commerce Platform Bobble Super

    The companies in the fifth cycle had to have a validated product, positive growth, the intention to move to the US within two years and revenues of at least $500,000

    Deloitte Launchpad Announces Fifth Cohort of Start-ups to Penetrate US Market